跳至主要内容
临床试验/NCT02316743
NCT02316743Unknown4 期

Beneficial Effects of Levothyroxine Supplementation in Patients With Systolic Heart Failure and Subclinical Hypothyroidism

Université de Sherbrooke1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2014年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
40
试验地点
1
主要终点
Performance at the 6 minutes walk test

研究概览

简要总结

The purpose of this study is to determine whether levothyroxine supplementation is beneficial in patients with systolic heart failure and subclinical hypothyroidism on the functional class evaluated with a 6 minute walk test.

详细描述

Forty patients with systolic heart failure and subclinical hypothyroidism will be include in a open label trial. They will receive levothyroxine supplementation to determine if their functional class will be affect.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Biochemical diagnosis of subclinical hypothyroidism (TSH between 3.5 and 10 with a normal T4)
  • Systolic heart failure with New-York Heart Association (NYHA) class II or III
  • Left ventricular ejection fraction under 40%
  • Stable heart failure for the past 3 months (no IV furosemide or hospital admission)
  • Beta-blockers and ACE inhibitors titrated to the maximum tolerated dose

排除标准

  • Isolated diastolic heart failure
  • Awaiting cardiac resynchronisation therapy
  • Impossibility to perform the 6 minutes walk test
  • Active cancer / Life expectancy under 18 months
  • Treatment with amiodarone

研究组 & 干预措施

Levothyroxine

Experimental

Levothyroxine supplementation

干预措施: Levothyroxine supplementation (Drug)

结局指标

主要结局

Performance at the 6 minutes walk test

时间窗: 6 months

次要结局

  • Difference of activin a measurement(6 months)
  • Difference of myostatin measurement(6 months)
  • Difference of systolic and diastolic function on transthoracic echocardiogram(6 months)
  • Arhythmic (ventricular arrhythmias and supraventricular arrythmias) and ischemic events (myocardial infarction, unstable angina and hospitalization for revascularization)(6 months)
  • Normalisation of thyroid workup(6 months)
  • Difference of the brain natriuretic peptide measurement(6 months)
  • Increase in heart rate measurement(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Paul Farand

Investigator

Université de Sherbrooke

研究点 (1)

Loading locations...

相似试验